The desire to focus on wildtype p53 was fueled by early experiments showing the ability of WT p53 restoration in previously cancerous cells to trigger cancer cell death or make these cells susceptible to chemotherapies (Ventura et al., 2007). Here, TP53 is linked to cancer.